15 Nov 2022
Applications for 2023 are now open.
March 1-4, 2023
Howard Johnson Escobar, Buenos Aires – Argentina
The aims of the Global Fellows Program 2023 are to provide up-to-date teaching in selected areas, practice critical thinking skills, offer the opportunity to present cases to faculty and peers, promote discussions and networking between younger and more senior physicians, and develop the next leaders in pediatric endocrinology. This program is being assembled by a committee of members from numerous participating Sisters Societies at the International Meeting of Pediatric Endocrinology 2023 (IMPE2023) and is open to fellows from these societies.
The program extends over 4 days and 3 nights and is composed of lectures, discussions, and interactive case presentations. In addition, there are planned activities for relaxation, team-building and socializing. It will be held at Howard Johnson Escobar located in Escobar, Buenos Aires, immediately prior to the International Meeting of Pediatric Endocrinology 2023 that will take place in Buenos Aires, Argentina.
The Sisters Societies organizing the Global Fellows Program 2023 are: SLEP, ESPE, PES, APEG, APPES, ASPAE, ASPED, CSPEM, ISPAE, GPED, ISPAD, and JSPE.
These are the rules to apply to be a fellow to Global Fellows Program 2023:
Applicants will be selected by the Global Fellows Program Steering Committee. There is no registration fee for the program.
Selected applicants will receive complimentary:
Air travel expenses will not be covered by the organizing program. Selected fellows are encouraged to apply for travel grants from the Sisters Society supporting their application.
We look forward to seeing you in Buenos Aires.
The 2023 Global Fellows Program steering committee:
|
New study suggests interacting with dogs can reduce cortisol levels
15 Mar 2024
Diabetes risk may be reduced by prioritising plant-based food
15 Mar 2024
Obesity in primary school aged girls linked to high incidence of musculoskeletal symptoms
15 Mar 2024
Risk of endometrial cancer associated with endocrine disrupting chemicals (EDCs)
15 Mar 2024